NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

23 hedge funds and large institutions have $139K invested in Navidea Biopharmaceuticals Inc. in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$35.8K
2 +$11.9K
3 +$11.6K
4
BFM
Boothbay Fund Management
New York
+$3.68K
5
TSS
Two Sigma Securities
New York
+$3.68K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$38K
2
$27K
3
$25.4K
4
$11.6K
5
$10.4K
6
$9.29K
7
$5.46K
8
$3.68K
9
$3.63K
10
$924
11
$920
12
$723
13
$505
14
$406
15
$290
16
$148
17
$55
18
$32
19
$28
20
$23
21
$10
22
$5
23
$1
24
25